Live demo — read only
Meridian Glove Co.: recover 280 bps without losing a customer.
Rubber and latex input costs are up 10% in 90 days. Competitors have already moved 3–5%. Meridian's realized prices stayed flat — and gross margin bled 291 bps in a single quarter. This is the exact diagnostic PriceShield runs on your own CSVs: deterministic math, honest confidence labels, and a customer-safe glidepath at the end.
Step 1 — What changed
The margin bleed is real, recent, and cost-driven
Monthly gross margin was stable for 21 months. The final quarter breaks the pattern — exactly when the rubber/latex index ramps. Costs moved; realized prices didn't.
Step 2 — Where the money is
Price Opportunity Map
Every family × segment cell scored on pricing power vs risk (the 3×3 matrix). Headline: $58.7K of annualized margin capture at just 50% realization of gap-to-target.
| Industrial safety buyers | Regional distributors | Small clinics | Government / public bid | Strategic hospital systems | |
|---|---|---|---|---|---|
| industrial | $5.6K defend | $8.5K selective increase | |||
| latex | $15.3K tighten floors | $11.8K aggressive increase | |||
| nitrile | $8.9K selective increase | $10.2K standard increase | $7.8K aggressive increase | $14.8K protect | $12.3K protect |
| surgical | $9.8K standard increase | $12.3K protect |
Step 3 — How much room
Price latitude: floor / target / stretch
Quantity-weighted realized-price envelopes per cell. 26.3% of revenue is priced below its own floor — that's the first wave of recovery, and it needs no list increase at all.
Shaded band: P25–P75 (inner) and P10–P90 (outer) of realized unit prices. Dashed line: current average. Dots: target (P60). Elasticity basis: simulated elasticity — shape-based (band).
Step 4 — What could break
Business-at-risk curve
Customers ranked by breakage risk score. Push the increase across the whole book and expected revenue-at-risk crosses churn tolerance near +1%. Recommended safe cap: 10% — Breakage Index 53/100.
- High price positions (weighted percentile 52.13) — top payers absorb further increases poorly
- Revenue concentration (weighted score 0.72) — large accounts carry the increase
- Increase shock at 5% of the 10% tolerance band
Step 5 — The plan
A 30/60/90-day price glidepath
Standard scenario (cap 8%, 80% realization): $28.7K of annualized margin back — 128 bps against the 280 bps goal — with $186.1K at risk, versus $224.4K of tolerance.
Mechanisms: discount tightening
Mechanisms: list increase, renewal step up
Mechanisms: list increase
Contract-locked strategic and government accounts route to renewal step-ups automatically; every clamped constraint is logged in the approval packet's exception log.
Run this on your own data.
Upload invoice history and a cost file — PriceShield maps the columns, scores the data, and returns a board-ready price action plan with an approval packet. Same deterministic math you just watched.
Start your own diagnostic